Physician profile
Andrea B Bourque
NPI 1861851057
$1,065.79
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $776 · 2023: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $152.41 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.12 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $104.83 | 2022 | |
| Alexion Pharmaceuticals, INC. | $80.13 | 2022-2023 | Soliris |
| Regeneron Healthcare Solutions, INC. | $66.26 | 2022 | |
| United Therapeutics Corporation | $61.26 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.57 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $51.05 | 2022 | |
| Mylan Specialty L.P. | $47.36 | 2022 | |
| Genzyme Corporation | $41.97 | 2022 | |
| Novartis Pharmaceuticals Corporation | $40.25 | 2021-2022 | |
| Ucb, INC. | $40.22 | 2022 | |
| Merck Sharp & Dohme LLC | $34.89 | 2022 | |
| Electromed, INC. | $30.21 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $29.73 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $20.31 | 2022 | |
| Melinta Therapeutics, LLC | $19.20 | 2022 | |
| Pfizer INC. | $18.84 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $18.58 | 2022 | |
| Paratek Pharmaceuticals, INC. | $13.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Bourque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.